Kava / Kava Kava

Kava, the ceremonial root drink of the Pacific Islands, has attracted serious oncology interest due to its unique flavokavain compounds. Flavokavain A and B induce apoptosis in bladder, breast, and prostate cancer cells through Bcl-2/Bax pathway modulation and NF-κB inhibition at doses achievable with normal supplementation. Epidemiological data from Pacific island nations — where kava consumption is traditionally very high — shows consistently lower rates of certain cancers, particularly bladder cancer. A landmark USC study (2009) demonstrated flavokavain B selectively kills bladder cancer cells while sparing normal bladder tissue, making it one of the few natural compounds with bladder-cancer-specific evidence. Beyond direct anti-tumour effects, kavalactones (kavain, dihydrokavain, methysticin) reduce anxiety, improve sleep quality, and lower cortisol — profoundly important for cancer patients where psychological stress significantly worsens outcomes.